Review of Tumor Dormancy Therapy Using Traditional Oriental Herbal Medicine

다국어 초록 (Multilingual Abstract)

Objective: Standard cancer therapy prolongs survival,but can be detrimental to the quality of life,compromise the immune system, and leave residual disease that can cause recurrence years or decades in the future. Tumor dormancy therapy is a novel therapeutic approach that may improve these shortcomings, promote quality of life, and prolong survival. The aim of this study was to analyze studies on dormancy therapy, especially studies using traditional Oriental herbal medicine, so as to evaluate the efficacy of dormancy therapy with traditional oriental herbal medicine.
Methods: We conducted a systematic literature review using Scientific and Technical Information Integration Services (NDSL), PubMed, and RISS. We searched for clinical reports, papers, and books related to tumor metastasis, recurrence, immunotherapy, tumor dormancy, and traditional oriental herbal medicine with anticancer effects. Seventy-nine (79) experimental and clinical articles in both Korean and English were reviewed. This study was conducted from March 1,2012 to May 31, 2012.
Results: This approach, Tumor dormancy therapy,rather than seeking to remove the tumor, includes combination of low-dose chemotherapy, immunotherapy,immunosurveillance, and other methods to stabilize tumor growth and to enhance the host is immunity against disseminated tumor cells and thus to manage cancer as a chronic disease while maintaining quality of life. In particular, integrative use of Oriental herbal medicine has been shown to induce or maintain tumor dormancy, increase the effectiveness of conventional chemotherapy, improve quality of life, and prolong survival.
Conclusion: Tumor dormancy therapy is a promising novel therapeutic approach that may be especially effective with Oriental herbal medicine. Further research is needed to determine its potential mechanisms and therapeutic applications.

참고문헌 (Reference)

1 강경아, "서울시 일 지역 주민의 인생회고 및 죽음준비 인식" 한국호스피스완화의료학회 14 (14): 81-90, 2011

2 Brackstone M, "Tumour dormancy in breast cancer: an update" 9 (9): 208-, 2007

3 Udagawa T, "Tumor dormancy of primary and secondary cancers" 116 (116): 615-628, 2008

4 Aguirre Ghiso JA, "Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling" 147 (147): 89-104, 1999

5 Gimbrone MA Jr, "Tumor dormancy in vivo by prevention of neovascularization" 136 (136): 261-276, 1972

6 Quesnel B, "Tumor dormancy and immunoescape" 116 (116): 685-694, 2008

7 Shachaf CM, "Tumor dormancy and MYC inactivation: pushing cancer to the brink of normalcy" 65 (65): 4471-4474, 2005

8 Ryschich E, "Transformation of the microvascular system during multistage tumorigenesis" 97 (97): 719-725, 2002

9 Wieder T, "T cell-mediated help against tumors" 7 (7): 2974-2977, 2008

10 Hsieh TC, "Suppression of proliferation and oxidative stress by extracts of Ganoderm alucidum in the ovarian cancer cell line OVCAR-3" 28 (28): 1065-1069, 2011

11 Hohaus S, "Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer" 79 (79): 1500-1507, 1999

12 Camargo MC, "Sex hormones, hormonal interventions, and gastric cancer risk: ameta-analysis" 21 (21): 20-38, 2012

13 Li Q, "SFECO2 extract from Typhoniumgiganteum Engl. tubers, induces apoptosis in human hepatoma SMMC-7721 cells involvement of a ROS-mediated mitochondrial pathway" 16 (16): 8228-8242, 2011

14 Riethdorf S, "Review: biological relevance of disseminated tumor cells in cancer patients" 123 (123): 1991-2006, 2008

15 Watnick RS, "Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis" 3 (3): 219-231, 2003

16 Goodison S, "Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein" 9 (9): 3808-3814, 2003

17 Becker S, "Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients" 106 (106): 239-243, 2007

18 Hart IR, "Perspective: tumour spread--the problems of latency" 187 (187): 91-94, 1999

19 Wang WB, "Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90" 227 (227): 2196-2206, 2012

20 Harach HR, "Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study" 56 (56): 531-538, 1985

21 Cho CK, "New therapy strategy to prevent cancer recurrence and metastasis" Garim Publishers 80-104, 2009

22 Aguirre-Ghiso JA, "Models, mechanisms and clinical evidence for cancer dormancy" 7 (7): 834-846, 2007

23 Braun S, "Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients" 18 (18): 80-86, 2000

24 Barkan D, "Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton" 68 (68): 6241-6250, 2008

25 Nagayama Y, "Inhibition of angiogenesis and tumorigenesis, and induction of dormancy by p53 in a p53-null thyroid carcinoma cell line in vivo" 20 (20): 2723-2728, 2000

26 Aguirre Ghiso JA, "Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo" 21 (21): 2513-2524, 2002

27 Chambers AF, "Influence of diet on metastasis and tumor dormancy" 26 (26): 61-66, 2009

28 Naumov GN, "Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases" 82 (82): 199-206, 2003

29 Hoffman RM, "In vivo real-time imaging of nuclearcytoplasmic dynamics of dormancy, proliferation and death of cancer cells" 116 (116): 716-729, 2008

30 Cho CK, "Healthy herbal cancer treatment" Taewoong Publishing 79-166, 2003

31 Jiang J, "Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA" 415 (415): 325-329, 2011

32 MacKie RM, "Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery, In Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery" 348 (348): 567-568, 2003

33 Liu YH, "Effects of a Chinese herbal medicine, Guan-Jen- Huang (Aeginetiaindica Linn.), on renal cancer cell growth and metastasis" 2012

34 Wu DC, "Effects of Pinus massoniana bark extract on the adhesion and migration capabilities of HeLa cells" 82 (82): 1202-1205, 2011

35 Lin J, "Effect of Hedyotis Diffusa Willd extract on tumor angiogenesis" 4 (4): 1283-1288, 2011

36 Aguirre-Ghiso JA, "ERK (MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38 (SAPK)" 63 (63): 1684-1695, 2003

37 Holmgren L, "Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression" 1 (1): 149-153, 1995

38 Uhr JW, "Dormancy in a model of murine B cell lymphoma" 11 (11): 277-283, 2001

39 Kruger WH, "Disseminated breast cancer cells prior to and after high-dose therapy" 10 (10): 681-689, 2001

40 Witzig TE, "Detection of circulating cytokeratinpositive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy" 8 (8): 1085-1091, 2002

41 Pantel K, "Detection and clinical implications of early systemic tumor cell dissemination in breast cancer" 9 (9): 6326-6334, 2003

42 Lage A, "Control of advanced cancer: the road to chronicity" 8 (8): 683-697, 2011

43 Xu W, "Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/beta-catenin pathway" 30 (30): 103-, 2011

44 Rosenberg R, "Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood" 49 (49): 150-158, 2002

45 Mehes G, "Combined automatic immunological and molecular cytogenetic analysis allows exact identification and quantification of tumor cells in the bone marrow" 7 (7): 1969-1975, 2001

46 Bureau of the Census, "Cancer registration statistics, incidence of cancer (61 kinds), age standardized incidence"

47 Cho CK, "Cancer dormancy therapy that makes prolong survival time by preventing recurrence and metastasis" Dajung books Publishers 15-174, 2005

48 Hong SH, "Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells" 27 (27): 114-120, 2012

49 Nielsen M, "Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies" 56 (56): 814-819, 1987

50 Tan W, "Berberine hydrochloride: anticancer activity and nanoparticulate delivery system" 6 : 1773-1777, 2011

51 Mehes G, "Automatic detection and genetic profiling of disseminated neuroblastoma cells" 36 (36): 205-209, 2001

52 Holmgren L, "Antiangiogenis restricted tumor dormancy" 15 (15): 241-245, 1996

53 Telang NT, "Anti-proliferative effects of Chinese herb Cornusofficinalis in a cell culture model for estrogen receptor-positive clinical breast cancer" 5 (5): 22-28, 2012

54 Zhong ZF, "Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo" 141 (141): 721-727, 2012

55 O'Reilly MS, "Angiostatin induces and sustains dormancy of human primary tumors in mice" 2 (2): 689-692, 1996

56 Black WC, "Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy" 328 (328): 1237-1243, 1993

57 Koebel CM, "Adaptive immunity maintains occult cancer in an equilibrium state" 450 (450): 903-907, 2007

58 Kummar S, "A phase I study of the Chinese herbal medicine PHY906 as a modulator of irinotecanbased chemotherapy in patients with advanced colorectal cancer" 10 (10): 85-96, 2011

59 김진희, "2005년 암의 경제적 비용부담 추계" 대한예방의학회 42 (42): 190-198, 2009